Subfoveal Choroidal Thickness After Surgery for Age-related Cataracts

NCT02895074 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2016-09-09

No results posted yet for this study

Summary

To compare the effects of femtosecond laser-assisted cataract surgery (FLACS) and conventional phacoemulsification surgery (CPS) on subfoveal choroidal thickness (SFCT) in age-related cataracts.

Conditions

  • Cataract

Interventions

PROCEDURE

Femtosecond laser-assisted cataract surgery

A femtosecond laser (Alcon-Lensx, Alcon-Lensx, Inc.) was used in this study. After pupil dilation and topical anesthesia, the laser was docked to the eye using a curved contact lens to applanate the cornea. With the integrated OCT imaging system, the locations of the cornea and the anterior and posterior surfaces of the crystalline lens were determined. A 5.0-mm-diameter capsulotomy was created by scanning a cylindrical pattern and followed by lens fragmentation. The laser was disconnected, and the remainder of the surgery was performed as phacoemulsification (Infiniti® Vision System; Alcon, USA). Folded intraocular lenses (IOLs) were implanted in the capsular bags.

PROCEDURE

Conventional phacoemulsification cataract surgery

Phacoemulsification was performed through a temporal 3.2-mm clear corneal incision with the same machine and followed by IOLs implantation.

DRUG

Tropicamide

After pupil dilation, 1 drop of tropicamide (0.5%) was applied every 15 minutes for 3 applications

DRUG

Proparacaine hydrochloride

topical anesthesia with proparacaine hydrochloride (0.5%) was applied.

Sponsors & Collaborators

  • Ministry of Health, China

    collaborator OTHER_GOV
  • Sun Yat-sen University

    lead OTHER

Principal Investigators

  • Haotian Lin, M.D., Ph.D · Zhongshan Ophthalmic Center, Sun Yat-sen University

  • Yizhi Liu, M.D., Ph.D · Zhongshan Ophthalmic Center, Sun Yat-sen University

  • Weirong Chen, M.D. · Zhongshan Ophthalmic Center, Sun Yat-sen University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02895074 on ClinicalTrials.gov